Changes of blood coagulation indicators in patients with primary liver cancer before and after TACE and its clinical significance

›› 2010, Vol. 25 ›› Issue (02): 110-112.

• 临床检验与血液学检验论著 • Previous Articles Next Articles

Changes of blood coagulation indicators in patients with primary liver cancer before and after TACE and its clinical significance

WANG Yanchun;LIU Shuye;DUAN Ying;GU Chungang

Tianjin Third Central Hospital, Tianjin 300170, China;Tianjin Medical University, Tianjin 300070, China

Received:2010-02-01 Online:2010-02-01 Published:2010-02-01

Abstract

CLC Number:

R446.11

WANG Yanchun;LIU Shuye;DUAN Ying;GU Chungang. Changes of blood coagulation indicators in patients with primary liver cancer before and after TACE and its clinical significance [J]. , 2010, 25(02): 110-112.

[1]	WU Sujun, JI Hengtao, PENG Mengle. Clinical values of IL-18,IL-37,NLRP3 and NK/DC ratio in hepatitis B-related liver cirrhosis [J]. Laboratory Medicine, 2022, 37(6): 518-523.
[2]	WANG Zhifeng, ZHOU Yang, DING Yina, DANG Jianhong, HU Dian, JIN Zhijun. Roles of peripheral blood inflammatory factors and coagulation indicators in endometriosis patients with pelvic adhesion [J]. Laboratory Medicine, 2021, 36(10): 1050-1054.
[3]	XIAO Xiao, GAO Chunfang. Research and application progress of circulating tumor cells in primary liver cancer [J]. Laboratory Medicine, 2019, 34(7): 661-666.
[4]	MENG Zhimin, ZHU Jie, ZHANG Chunyan, GUO Wei, PAN Baishen, WANG Beili. Relationship between peripheral blood lymphocyte subset and prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization [J]. Laboratory Medicine, 2018, 33(9): 781-785.

Changes of blood coagulation indicators in patients with primary liver cancer before and after TACE and its clinical significance

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics